These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 23303302

  • 1. Fucoidan extract enhances the anti-cancer activity of chemotherapeutic agents in MDA-MB-231 and MCF-7 breast cancer cells.
    Zhang Z, Teruya K, Yoshida T, Eto H, Shirahata S.
    Mar Drugs; 2013 Jan 09; 11(1):81-98. PubMed ID: 23303302
    [Abstract] [Full Text] [Related]

  • 2. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.
    Arisan ED, Kutuk O, Tezil T, Bodur C, Telci D, Basaga H.
    Breast Cancer Res Treat; 2010 Jan 09; 119(2):271-81. PubMed ID: 19238538
    [Abstract] [Full Text] [Related]

  • 3. Bag-1 silencing enhanced chemotherapeutic drug-induced apoptosis in MCF-7 breast cancer cells affecting PI3K/Akt/mTOR and MAPK signaling pathways.
    Kilbas PO, Akcay IM, Doganay GD, Arisan ED.
    Mol Biol Rep; 2019 Feb 09; 46(1):847-860. PubMed ID: 30661182
    [Abstract] [Full Text] [Related]

  • 4. Grifola frondosa polysaccharides induce breast cancer cell apoptosis via the mitochondrial-dependent apoptotic pathway.
    Zhang Y, Sun D, Meng Q, Guo W, Chen Q, Zhang Y.
    Int J Mol Med; 2017 Oct 09; 40(4):1089-1095. PubMed ID: 28765878
    [Abstract] [Full Text] [Related]

  • 5. Synergistic anticancer effects of a bioactive subfraction of Strobilanthes crispus and tamoxifen on MCF-7 and MDA-MB-231 human breast cancer cell lines.
    Yaacob NS, Kamal NN, Norazmi MN.
    BMC Complement Altern Med; 2014 Jul 18; 14():252. PubMed ID: 25034326
    [Abstract] [Full Text] [Related]

  • 6. ER+ Breast Cancer Strongly Depends on MCL-1 and BCL-xL Anti-Apoptotic Proteins.
    Alcon C, Gómez Tejeda Zañudo J, Albert R, Wagle N, Scaltriti M, Letai A, Samitier J, Montero J.
    Cells; 2021 Jul 02; 10(7):. PubMed ID: 34359829
    [Abstract] [Full Text] [Related]

  • 7. Caspase-dependent and caspase-independent induction of apoptosis in breast cancer by fucoidan via the PI3K/AKT/GSK3β pathway in vivo and in vitro.
    Xue M, Ji X, Xue C, Liang H, Ge Y, He X, Zhang L, Bian K, Zhang L.
    Biomed Pharmacother; 2017 Oct 02; 94():898-908. PubMed ID: 28810530
    [Abstract] [Full Text] [Related]

  • 8. Fucoidan induces G1 phase arrest and apoptosis through caspases-dependent pathway and ROS induction in human breast cancer MCF-7 cells.
    Banafa AM, Roshan S, Liu YY, Chen HJ, Chen MJ, Yang GX, He GY.
    J Huazhong Univ Sci Technolog Med Sci; 2013 Oct 02; 33(5):717-724. PubMed ID: 24142726
    [Abstract] [Full Text] [Related]

  • 9. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway.
    Huang KF, Zhang GD, Huang YQ, Diao Y.
    Int Immunopharmacol; 2012 Feb 02; 12(2):334-41. PubMed ID: 22182776
    [Abstract] [Full Text] [Related]

  • 10. Centaurea cyanus extracted 13-O-acetylsolstitialin A decrease Bax/Bcl-2 ratio and expression of cyclin D1/Cdk-4 to induce apoptosis and cell cycle arrest in MCF-7 and MDA-MB-231 breast cancer cell lines.
    Keyvanloo Shahrestanaki M, Bagheri M, Ghanadian M, Aghaei M, Jafari SM.
    J Cell Biochem; 2019 Oct 02; 120(10):18309-18319. PubMed ID: 31161672
    [Abstract] [Full Text] [Related]

  • 11. Effects of Fucoidan and Chemotherapeutic Agent Combinations on Malignant and Non-malignant Breast Cell Lines.
    Abudabbus A, Badmus JA, Shalaweh S, Bauer R, Hiss D.
    Curr Pharm Biotechnol; 2017 Oct 02; 18(9):748-757. PubMed ID: 29141543
    [Abstract] [Full Text] [Related]

  • 12. Tumor suppressor BLU promotes paclitaxel antitumor activity by inducing apoptosis through the down-regulation of Bcl-2 expression in tumorigenesis.
    Park ST, Byun HJ, Kim BR, Dong SM, Park SH, Jang PR, Rho SB.
    Biochem Biophys Res Commun; 2013 May 24; 435(1):153-9. PubMed ID: 23628417
    [Abstract] [Full Text] [Related]

  • 13. Dietary isoflavone daidzein synergizes centchroman action via induction of apoptosis and inhibition of PI3K/Akt pathway in MCF-7/MDA MB-231 human breast cancer cells.
    Kaushik S, Shyam H, Sharma R, Balapure AK.
    Phytomedicine; 2018 Feb 01; 40():116-124. PubMed ID: 29496164
    [Abstract] [Full Text] [Related]

  • 14. Anthocyanins Isolated from Vitis coignetiae Pulliat Enhances Cisplatin Sensitivity in MCF-7 Human Breast Cancer Cells through Inhibition of Akt and NF-κB Activation.
    Paramanantham A, Kim MJ, Jung EJ, Kim HJ, Chang SH, Jung JM, Hong SC, Shin SC, Kim GS, Lee WS.
    Molecules; 2020 Aug 09; 25(16):. PubMed ID: 32784919
    [Abstract] [Full Text] [Related]

  • 15. Regulation of BAX and BCL-2 expression in breast cancer cells by chemotherapy.
    Gibson LF, Fortney J, Magro G, Ericson SG, Lynch JP, Landreth KS.
    Breast Cancer Res Treat; 1999 May 09; 55(2):107-17. PubMed ID: 10481938
    [Abstract] [Full Text] [Related]

  • 16. Piper nigrum ethanolic extract rich in piperamides causes ROS overproduction, oxidative damage in DNA leading to cell cycle arrest and apoptosis in cancer cells.
    de Souza Grinevicius VM, Kviecinski MR, Santos Mota NS, Ourique F, Porfirio Will Castro LS, Andreguetti RR, Gomes Correia JF, Filho DW, Pich CT, Pedrosa RC.
    J Ethnopharmacol; 2016 Aug 02; 189():139-47. PubMed ID: 27178634
    [Abstract] [Full Text] [Related]

  • 17. Antitumor activity of HM781-36B, a pan-HER tyrosine kinase inhibitor, in HER2-amplified breast cancer cells.
    Kim HJ, Kim HP, Yoon YK, Kim MS, Lee GS, Han SW, Im SA, Kim TY, Oh DY, Bang YJ.
    Anticancer Drugs; 2012 Mar 02; 23(3):288-97. PubMed ID: 23422737
    [Abstract] [Full Text] [Related]

  • 18. Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling.
    Sinha S, Sharma S, Vora J, Shah H, Srivastava A, Shrivastava N.
    J Ethnopharmacol; 2018 May 10; 217():23-35. PubMed ID: 29427634
    [Abstract] [Full Text] [Related]

  • 19. Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer.
    Vallet S, Fan F, Malvestiti S, Pecherstorfer M, Sattler M, Schneeweiss A, Schulze-Bergkamen H, Opferman JT, Cardone MH, Jäger D, Podar K.
    Breast Cancer Res Treat; 2019 Feb 10; 173(3):585-596. PubMed ID: 30374681
    [Abstract] [Full Text] [Related]

  • 20. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
    Wang Z, Goulet R, Stanton KJ, Sadaria M, Nakshatri H.
    Anticancer Res; 2005 Feb 10; 25(3c):2367-79. PubMed ID: 16080463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.